BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 1332100)

  • 1. The brain as a target for adrenocortical steroids: cognitive implications.
    Martignoni E; Costa A; Sinforiani E; Liuzzi A; Chiodini P; Mauri M; Bono G; Nappi G
    Psychoneuroendocrinology; 1992 Aug; 17(4):343-54. PubMed ID: 1332100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercortisolemia and depression.
    Gillespie CF; Nemeroff CB
    Psychosom Med; 2005; 67 Suppl 1():S26-8. PubMed ID: 15953796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin, Cushing's disease, and depression.
    Sonino N; Fava GA
    Psychother Psychosom; 1996; 65(2):63-5. PubMed ID: 8711083
    [No Abstract]   [Full Text] [Related]  

  • 4. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
    Fukata J; Shimizu N; Imura H; Hibi I; Tanaka K; Tanaka T; Nakagawa S; Takebe K; Kimura K; Yoshinaga K
    Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventral subiculum regulates hypothalamo-pituitary-adrenocortical and behavioural responses to cognitive stressors.
    Herman JP; Dolgas CM; Carlson SL
    Neuroscience; 1998 Sep; 86(2):449-59. PubMed ID: 9881860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
    Isidori AM; Kaltsas GA; Korbonits M; Pyle M; Gueorguiev M; Meinhardt A; Metz C; Petrovsky N; Popovic V; Bucala R; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits.
    Raber J
    Mol Neurobiol; 1998 Aug; 18(1):1-22. PubMed ID: 9824846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor.
    Gold PW; Chrousos G; Kellner C; Post R; Roy A; Augerinos P; Schulte H; Oldfield E; Loriaux DL
    Am J Psychiatry; 1984 May; 141(5):619-27. PubMed ID: 6324597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin releasing factor: basic studies and clinical applications.
    Chrousos GP; Calabrese JR; Avgerinos P; Kling MA; Rubinow D; Oldfield EH; Schuermeyer T; Kellner CH; Cutler GB; Loriaux DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):349-59. PubMed ID: 2999871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hypothalamic-pituitary-adrenocortical axis in major depression.
    Stokes PE; Sikes CR
    Neurol Clin; 1988 Feb; 6(1):1-19. PubMed ID: 2837631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hypothalamic-pituitary-adrenal axis in depression.
    Meltzer HY; Lowy MT; Koenig JI
    Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885
    [No Abstract]   [Full Text] [Related]  

  • 13. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs.
    Gold PW; Licinio J; Wong ML; Chrousos GP
    Ann N Y Acad Sci; 1995 Dec; 771():716-29. PubMed ID: 8597444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
    Tajima-Pozo K; Montes-Montero A; Güemes I; González-Vives S; Díaz-Marsá M; Carrasco JL
    Endocrinol Nutr; 2013; 60(7):396-403. PubMed ID: 23623464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical Cushing's syndrome is a potential cause of metabolic dementia and rapidly progressive Alzheimer-type dementia.
    Guldiken S; Guldiken B
    Med Hypotheses; 2008 Nov; 71(5):703-5. PubMed ID: 18801622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the neurohypophysis in psychological stress].
    Scantamburlo G; Ansseau M; Legros JJ
    Encephale; 2001; 27(3):245-59. PubMed ID: 11488255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress.
    Tsigos C; Chrousos GP
    J Psychosom Res; 2002 Oct; 53(4):865-71. PubMed ID: 12377295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
    Tanaka T; Hibi I; Shimizu N; Imura H; Tanaka K; Fukata J; Fujieda K; Ichimura T; Kuribayashi T; Ito K
    Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder.
    Yehuda R; Giller EL; Southwick SM; Lowy MT; Mason JW
    Biol Psychiatry; 1991 Nov; 30(10):1031-48. PubMed ID: 1661614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.